TMV-018 / Max Planck Institute, Merck (MSD)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TMV-018 / Merck (MSD), Max Planck Institute
NCT04195373: A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract

Withdrawn
1
0
Europe
TMV-018 + 5-FC, TMV-018 + anti-PD-1, TMV-018 + 5-FC + anti-PD-1
Themis Bioscience GmbH, Assign Data Management and Biostatistics GmbH, SSS International Clinical Research GmbH
Gastrointestinal Cancer
11/20
11/20

Download Options